Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Advances in Pharma Business Management and Research

Volume 1
BuchKartoniert, Paperback
85 Seiten
Englisch
Springererschienen am18.09.20201st ed. 2020
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'.The chapters are summaries of master´s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.mehr
Verfügbare Formate
BuchGebunden
EUR53,49
BuchKartoniert, Paperback
EUR53,49

Produkt

KlappentextThis open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'.The chapters are summaries of master´s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.
Zusammenfassung
Unique combination of management and pharmaceutical content

Cutting edge information of scientific and practical issues in the pharmaceutical industry

Explorations of pharmaceutical late-breaking topics where science meets business
Details
ISBN/GTIN978-3-030-35920-1
ProduktartBuch
EinbandartKartoniert, Paperback
Verlag
Erscheinungsjahr2020
Erscheinungsdatum18.09.2020
Auflage1st ed. 2020
Seiten85 Seiten
SpracheEnglisch
IllustrationenX, 85 p. 11 illus.
Artikel-Nr.49042793

Inhalt/Kritik

Inhaltsverzeichnis
Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry.- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context.- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company.- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies.- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee´s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi.- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership.- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.mehr

Schlagworte

Autor

Dr. Lars Schweizer

Prof. Dr. Lars Schweizer has been a Professor of Strategic Management at Goethe University Frankfurt since December 2007. Currently, he is the Academic Director of the Master of Pharma Business Administration as well as the Master of Digital Transformation at Goethe Business School. He holds a doctoral degree and postdoctoral degree (habilitation) from the University of Bamberg. He has published papers in journals such as the Academy of Management Journal, the Strategic Management Journal, the Journal of Management, Industrial and Corporate Change, the Journal of General Management, Scandinavian Journal of Management, the Journal of Engineering and Technology Management, the International Journal of Biotechnology, Pharmaceutical Policy and Law, and the Journal of Business Research. His main research focuses are mergers & acquisitions, strategic management, leadership, and organizational behavior as well as the pharmaceutical and biotechnology industries.
Weitere Artikel von
Herausgegeben:Schweizer, Lars
Weitere Artikel von
Russe, Otto Quintus